Medscape Medical NewsAll articles

PeraServer and PeraTrend

PeraHealth, Inc. • Cardiovascular • 05/01/2018

510(k)IEC 62304 Class C
FDA Summary PDF

Device Purpose

The PeraServer and PeraTrend System is a software platform that calculates and displays the Rothman Index, a composite score derived from patient EHR data including vital signs, nursing assessments, and lab values. Its purpose is to provide healthcare professionals with a quantitative measure of patient physiological status and statistical mortality risk, thereby serving as an adjunct to clinical decision support across various hospital settings.

Summary

The PeraServer and PeraTrend System is a software-based medical device designed to assist healthcare providers in assessing patient condition. PeraServer, the backend component, imports electronic health record (EHR) data, encompassing vital signs, nursing assessments, and laboratory results, to compute the Rothman Index (RI) score. This RI score, along with associated configurable warnings, is stored for analysis. PeraTrend serves as the frontend, web-based user interface, enabling clinicians to view, display, and trend these RI scores and related measures, providing graphical representations over time and comparisons of the RI with its input data. The Rothman Index itself is a single, quantitative measure reflecting a patient's overall physiologic status, derived from the aggregate statistical mortality risk associated with the values of their vital signs, nursing assessments, and selected lab data. The PeraServer/PeraTrend system is intended for use throughout hospital settings, such as emergency departments, general wards, and intensive care units, for neonatal, pediatric, and adult patients, although it is not intended for use in the Neonatal Intensive Care Unit. Retrospective studies have been conducted to validate the mechanics of both adult and pediatric RI scores and to compare the RI with other early warning systems like MEWS, demonstrating its performance in reflecting underlying patient conditions.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Rothman IndexPeraServerPeraTrendPatient Status IndexClinical Decision SupportEHR Data IntegrationVital Signs MonitoringNursing Assessment DataLab Data AnalysisMortality Risk Assessment

Device Metadata

Submission Number
K172959
Company
PeraHealth, Inc.
Panel
Cardiovascular
Product Code
N/A
Data Type
Signals
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the Rothman Index's algorithm specifically weigh different input parameters (vital signs, nursing assessments, labs) and how sensitive is it to variations in individual data points?; What are the computational requirements and typical EHR integration challenges encountered when deploying the PeraServer backend in diverse hospital IT environments?; What specific training or protocols are recommended for clinical staff to effectively interpret PeraTrend displays and integrate Rothman Index scores into their decision-making processes without over-reliance?; Beyond general mortality risk, how has the Rothman Index been validated for predicting specific clinical deterioration events or guiding targeted interventions in neonatal, pediatric, and adult populations?; What is the performance of the PeraServer/PeraTrend system when dealing with rapidly changing patient conditions, and how frequently are Rothman Index scores updated from EHR data?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score30/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan✓ Detected in Summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(server, platform, backend)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
PeraServer and PeraTrend - PeraHealth, Inc. | ESL FDA AI Device Intelligence